At $2,215M market cap with a Price/Sales of 47 and a Forward P/E listed at 500+, the market is pricing in an almost flawless long-term recovery despite current earnings distress. EPS sits at -188.6 with operating margins at -8.20% and ROIC at -7.70%, meaning the company is destroying capital while trading at venture-style multiples. The Altman Z-Score of 73.2 suggests virtually no near-term bankruptcy risk, reinforced by a Current Ratio of 11, but financial safety is not the same as valuation discipline. This is a liquidity-rich but profitability-poor business being priced as if hypergrowth and margin normalization are inevitable; the asymmetry currently favors disappointment rather than upside surprise.